Advocacy organizations such as the National Alliance for the Mentally Ill (NAMI) and patient consumer groups are playing an ever-increasing role in public health policy and patient care in schizophrenia.
The recovery philosophy which recognizes the unique contributions of those who have experienced mental illness is now a part of treatment approaches in many states.
Several states have extended these consumer initiatives to incorporate advance directives, an approach that has generated much debate.
The NAMI destigmatization campaign, grounded in the neurobiology of major mental illness, is an unprecedented, concerted effort to change public opinion and to achieve parity at all levels for persons with severe and persistent mental illness.
This article describes and chronicles these initiatives and explores their implications for the management of schizophrenia into the next millennium.
Mots-clés Pascal : Schizophrénie, Traitement, Perception sociale, Attitude, Stigmate, Etats Unis, Amérique du Nord, Amérique, Historique, Santé mentale, Homme, Psychose
Mots-clés Pascal anglais : Schizophrenia, Treatment, Social perception, Attitude, Stigma, United States, North America, America, Case history, Mental health, Human, Psychosis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0266713
Code Inist : 002B18H02. Création : 11/09/1998.